By Alex Philippidis

NEW YORK (GenomeWeb News) – Australia's Prince of Wales Medical Research Institute (POWMRI) said it plans to start construction immediately on the A$42 million (US$38.6 million) phase — the first of four phases — of a new A$118 million building designed to enhance its research into brain injury and Alzheimer's and Parkinson's disease, following approval of the project's planning application earlier this month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.